Also trades as: FBIO (NASDAQ) · $vol 1M
FBIOP NASDAQ
Fortress Biotech, Inc.
1W: +1.4%
1M: -9.8%
3M: -16.6%
YTD: +66.1%
1Y: +124.5%
3Y: +46.7%
5Y: -12.3%
$16.86
+0.80 (+4.98%)
Weekly Expected Move ±3.6%
$16
$16
$17
$17
$18
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (13)
Fortress Biotech (NASDAQ:FBIOP) Stock Price Down 1% – What’s Next?
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
The Capital Allocation Dilemma for Fortress ($FBIO / $FBIOP): Pure Math vs. Governance & Reputation. What do you think management does here?
The Capital Allocation Dilemma for Fortress ($FBIO / $FBIOP): Pure Math vs. Governance & Reputation. What do you think management does here?
Fortress Biotech to Participate in A.G.P.'s Annual Virtual Healthcare Conference
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Fortress Biotech (NASDAQ:FBIOP) Stock Price Down 2.2% – Time to Sell?
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
Fortress Biotech (NASDAQ:FBIO) Shares Pass Above Two Hundred Day Moving Average – What’s Next?
Fortress Biotech (NASDAQ:FBIOP) Trading Down 0.1% – What’s Next?
Fortress Biotech (NASDAQ:FBIO) Stock Passes Above Two Hundred Day Moving Average – Here’s Why
Fortress Biotech (NASDAQ:FBIOP) Stock Price Up 22.9% – Here’s What Happened